IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
about
Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV InfectionRegulation of type I interferon responsesInterferons and viruses: an evolutionary arms race of molecular interactionsInterferon-γ Inhibits Ebola Virus InfectionContraction of the type I IFN locus and unusual constitutive expression of IFN-α in batsRNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammationThe Signal Transducer and Activator of Transcription 1 (STAT1) Inhibits Mitochondrial Biogenesis in Liver and Fatty Acid Oxidation in Adipocytes.Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation.Interferons and their stimulated genes in the tumor microenvironmentARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.Dual modulation of type I interferon response by bluetongue virus.A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer.STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugsMicroRNA-23b Promotes Avian Leukosis Virus Subgroup J (ALV-J) Replication by Targeting IRF1.Imaging of tumor clones with differential liver colonizationRoles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.STAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling PathwaysResponse to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancerThe intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.DNA damage response is hijacked by human papillomaviruses to complete their life cycleInterferons and the Immunogenic Effects of Cancer Therapy.An interaction map of circulating metabolites, immune gene networks, and their genetic regulation.IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling.BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6.Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells.Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome.STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling.Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses.The molecular basis for differential type I interferon signaling.High-throughput quantitative real-time RT-PCR assay for determining expression profiles of types I and III interferon subtypes.Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition.
P2860
Q26784252-449C2A7B-FB51-4E9F-8F53-D18D4DD1CB64Q26853177-E569CDE1-19DE-4ABB-B52D-A946F98BEF21Q28083788-EB53D0AF-1AF8-46F3-A4A1-13B4ACA9D483Q28550929-86101D8B-C2BC-4ABB-9933-2703DEC748FCQ28602705-F648445E-D371-4F8E-962E-28DF405FD85BQ28804081-9DA09DFB-FF26-448C-A2DE-6505E4AA6C7EQ30277884-4D881A6C-FDB1-4B3C-8C26-0A38BBD17A18Q33751085-84A16C5C-16FD-40E9-AB75-A0E332C6A044Q33988567-B13F7718-9195-40C3-9C9E-FC4D574C1892Q34148155-98E0765C-8656-4E3A-8DC4-045F1967E278Q34262097-2F39FDEC-AC8B-4E5D-B413-5BF55BBF1095Q34467421-CDD8835D-1EAE-4E1C-B261-628FC45E5CADQ34918110-07C1DA01-2E5D-4156-983C-63B1C698EC5EQ35206586-B5E1BC3A-2E80-406B-871F-980D34FAAE73Q35494968-CEBC4C3F-04D2-422F-8B36-BF3FD6449C66Q35567160-BC2AE7CA-36AC-42F4-A9D7-1C0E5FD3A4B0Q35616680-46B53B20-0372-4B8E-8970-5766134ED810Q35765080-7F2DF826-9EFD-4D23-948A-5FD11613C562Q35989977-0820A4DB-F118-42CB-ADF0-4A2A25445D62Q36174010-42231085-3095-4F76-907D-51E1DAFC160BQ36636150-E82A8B7E-147A-465B-8B03-B140EB19CEA8Q36750699-06C0387E-4412-4C3E-AE39-1C512F9E2CAFQ37518395-B8283E73-EE7A-44E8-A47E-01B29B1ED32BQ37543955-D3A720BE-D637-4EBF-AE74-00CB55645196Q37641644-9E34D4FA-8F03-4061-B265-E679F7359541Q37724792-3A2D16CA-FCC6-4191-B5EC-A08804EE8254Q38398206-7D37AF09-C112-4F65-9542-69090401873FQ38648346-C14C0BA5-A56B-45B1-915E-299E8E893D24Q38707618-A57AA945-BAD1-44CC-8D40-72379535EBDDQ38712385-5B2A313C-76D8-4802-8327-72CA284769B0Q38721807-DEC50465-D840-43AC-A93D-8A13C2BF80BBQ38728375-A5163422-6C5E-4EAF-A316-3901C92115F7Q38730491-63704A62-2D42-4EA8-AE42-5B8122101A12Q38793802-FAF77AFC-00E0-43D7-83FF-0E206AAC53A3Q38867618-C5F5814E-D047-4CC4-95E7-08A83EC4A86FQ38899854-351A0B55-A6A7-437B-B2B7-46DCAB3E7F71Q39128976-55C9183B-F8EF-458F-A9BF-DF5A1F4E8202Q39176574-B14342CC-DA8B-4022-B63B-629F83895E39Q39743537-8211E424-BF27-4713-AC5D-14C0FA2E187CQ40172758-D0549ACF-EEAA-43FE-B5C1-53721AE90A47
P2860
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@ast
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@en
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@en-gb
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@nl
type
label
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@ast
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@en
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@en-gb
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@nl
prefLabel
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@ast
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@en
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@en-gb
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@nl
P2093
P2860
P3181
P356
P1433
P1476
IFNβ-dependent increases in ST ...... ance to viruses and DNA damage
@en
P2093
Charles M Rice
Damian J Junk
Elise G Holvey-Bates
George R Stark
HyeonJoo Cheon
John W Schoggins
Mark W Jackson
Naoko Imanaka
P2860
P304
P3181
P356
10.1038/EMBOJ.2013.203
P407
P577
2013-10-16T00:00:00Z